Literature DB >> 19995129

Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat.

Harry L June1, Andrew Rong Song Tzeng Yang, Joseph L Bryant, Odell Jones, Walter Royal.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) transgenic (Tg) rat model incorporates a noninfectious viral genome that is under similar regulatory control mechanisms in vivo as those that exist with natural infection in humans. Vitamin A (VA) deficiency in humans has been associated with progressive systemic HIV disease and with impaired cognition in rodent models. The effects on of VA deficiency on the development of behavioral abnormalities with HIV infection have not been previously described. In these studies, wild-type (Wt) and Tg rats maintained on either a normal (VA+) or a VA-deficient (VA-) diet were examined for activity in an open field (horizontal activity, total distance, vertical activity, and rearing) and on rotarod testing. On both open field and rotarod testing, the Tg rats performed worse than the Wt rats, with the most severe deficits noted in the TgVA- animals. Analysis of the specific effects of the presence of the HIV transgene and the diet on the performance on the open field tests showed a dominant effect from the transgene on all of the tests, with an effect from the diet on only the number of rearings. On rotarod testing, effects form both the diet and the transgene were observed at lower speeds, at the highest speeds, and on the accelerating rotarod. These studies therefore demonstrate that behavioral and motor abnormalities can be detected in this model and are likely due to similar mechanisms by which humans infected with HIV might develop cognitive-motor impairment in association with VA deficiency.

Entities:  

Mesh:

Year:  2009        PMID: 19995129      PMCID: PMC3005340          DOI: 10.3109/13550280903350200

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  49 in total

1.  Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania.

Authors:  W W Fawzi; G Msamanga; D Hunter; E Urassa; B Renjifo; D Mwakagile; E Hertzmark; J Coley; M Garland; S Kapiga; G Antelman; M Essex; D Spiegelman
Journal:  J Acquir Immune Defic Syndr       Date:  2000-03-01       Impact factor: 3.731

Review 2.  Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force.

Authors:  R S Janssen; D R Cornblath; L G Epstein; J McArthur; R W Price
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

3.  Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.

Authors:  L Hudson; J Liu; A Nath; M Jones; R Raghavan; O Narayan; D Male; I Everall
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

4.  Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers.

Authors:  K S MacDonald; I Malonza; D K Chen; N J Nagelkerke; J M Nasio; J Ndinya-Achola; J J Bwayo; D S Sitar; F Y Aoki; F A Plummer
Journal:  AIDS       Date:  2001-03-30       Impact factor: 4.177

5.  Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients.

Authors:  Jonathan Corcoran; Po Lin So; Malcolm Maden
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

6.  Vitamin A deficiency produces spatial learning and memory impairment in rats.

Authors:  S Cocco; G Diaz; R Stancampiano; A Diana; M Carta; R Curreli; L Sarais; F Fadda
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.

Authors:  W Reid; M Sadowska; F Denaro; S Rao; J Foulke; N Hayes; O Jones; D Doodnauth; H Davis; A Sill; P O'Driscoll; D Huso; T Fouts; G Lewis; M Hill; R Kamin-Lewis; C Wei; P Ray; R C Gallo; M Reitz; J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

8.  Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum.

Authors:  A K Bansal; C F Mactutus; A Nath; W Maragos; K F Hauser; R M Booze
Journal:  Brain Res       Date:  2000-10-06       Impact factor: 3.252

9.  Deletion of GABAA receptor alpha 1 subunit-containing receptors alters responses to ethanol and other anesthetics.

Authors:  J E Kralic; M Wheeler; K Renzi; C Ferguson; T K O'Buckley; A C Grobin; A L Morrow; G E Homanics
Journal:  J Pharmacol Exp Ther       Date:  2003-02-11       Impact factor: 4.030

10.  Neonatal exposure to cocaine: altered dopamine levels in the amygdala and behavioral outcomes in the developing rat.

Authors:  Teresa Summavielle; Ana Magalhães; Ivone Castro-Vale; Liliana de Sousa; Maria Amélia Tavares
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

View more
  12 in total

1.  Effects of vitamin A deficiency and opioids on parvalbumin + interneurons in the hippocampus of the HIV-1 transgenic rat.

Authors:  Ming Guo; Joseph Bryant; Shireen Sultana; Odell Jones; Walter Royal
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

2.  Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2017-07-20       Impact factor: 2.643

3.  Male HIV-1 transgenic rats show reduced cocaine-maintained lever-pressing compared to F344 wildtype rats despite similar baseline locomotion.

Authors:  Y Wendy Huynh; Brady M Thompson; Christopher E Larsen; Shilpa Buch; Ming-Lei Guo; Rick A Bevins; Jennifer E Murray
Journal:  J Exp Anal Behav       Date:  2020-02-20       Impact factor: 2.468

4.  Age-Related Decrease in Tyrosine Hydroxylase Immunoreactivity in the Substantia Nigra and Region-Specific Changes in Microglia Morphology in HIV-1 Tg Rats.

Authors:  David R Goulding; Andrew Kraft; Peter R Mouton; Christopher A McPherson; Valeria Avdoshina; Italo Mocchetti; G Jean Harry
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

5.  Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.

Authors:  Walter Royal; Li Zhang; Ming Guo; Odell Jones; Harry Davis; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2012-04-12       Impact factor: 3.478

Review 6.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

7.  Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND.

Authors:  Guoku Hu; Ke Liao; Lu Yang; Gurudutt Pendyala; Yeonhee Kook; Howard S Fox; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-24       Impact factor: 4.147

8.  HIV Transgenic Rats Demonstrate Superior Task Acquisition and Intact Reversal Learning in the Within-Session Probabilistic Reversal Learning Task.

Authors:  Benjamin Z Roberts; Yinong V He; Muhammad Chatha; Arpi Minassian; Igor Grant; Jared W Young
Journal:  Cogn Affect Behav Neurosci       Date:  2021-07-26       Impact factor: 3.282

9.  Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats.

Authors:  Walter Royal; Adem Can; Todd D Gould; Ming Guo; Jared Huse; Myles Jackson; Harry Davis; Joseph Bryant
Journal:  J Neurovirol       Date:  2018-04-11       Impact factor: 2.643

10.  Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18F-FDG-PET.

Authors:  William C Reid; Rafael Casas; Georgios Z Papadakis; Siva Muthusamy; Dianne E Lee; Wael G Ibrahim; Anand Nair; Deloris Koziol; Dragan Maric; Dima A Hammoud
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.